MARC details
| 000 -LEADER |
| fixed length control field |
03123cam a22003858i 4500 |
| 001 - CONTROL NUMBER |
| control field |
14632082 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
EG-NcFUE |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20230502090149.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
061113s2008 stk f b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780443102851 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0443102856 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780443102868 (International ed.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0443102864 (International ed.) |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
615.58 |
| Edition number |
22 |
| Item number |
W.R.C |
| 245 00 - TITLE STATEMENT |
| Title |
Clinical pharmacy and therapeutics / |
| Statement of responsibility, etc |
edited by Roger Walker, Cate Whittlesea. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
4th edtions |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Edinburgh ; |
| -- |
New York : |
| Name of publisher, distributor, etc |
Churchill Livingstone, |
| Date of publication, distribution, etc |
2007 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xii , 900 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
30 cm |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Section 1: General Clinical pharmacy process. Prescribing. Practical pharmacokinetics. Drug interactions. Adverse drug reactions. Laboratory data. Parenteral nutrition. Pharmacokinetics. Section 2: Life stages Neonates. Paediatrics. Geriatrics. Section 3: Therapeutics Gastrointestinal disorders: Peptic ulcer disease. Inflammatory bowel disease. Constipation and diarrhoea. Hepatic disorders:Adverse effects of drugs on the liver. Liver disease. Renal disorders: Chronic kidney disease and end-stage renal failure. Acute renal failure. Cardiovascular disorders: Hypertension. Coronary heart disease. Chronic heart failure. Cardiac arrhythmias. Thrombosis. Dyslipidaemia. Respiratory disorders: Asthma. Chronic obstructive pulmonary disease. Drug-induced lung disease. Neurological and psychological disorders: Insomnia and anxiety. Affective disorders. Schizophrenia. Epilepsy. Parkinson's disease. Pain. Nausea and vomiting. Infections: Respiratory infections. Urinary tract infections. Gastrointestinal infections. Infective meningitis. Surgical antibiotic prophylaxis. Tuberculosis. HIV infection. Fungal infections. Endocrine disorders: Thyroid and parathyroid disorders. Diabetes mellitus. Obstetric and gynaecological disorders: Menstrual cycle disorders. Menopause. Drugs in pregnancy and lactation. Urological disorders: Benign prostatic hyperplasia. Haemotopoietic disorders: Anaemia. Malignant disorders: Leukaemia. Lymphomas. Solid tumours. Rheumatic disorders: Rheumatoid arthritis and osteoarthritis. Gout and hyperuricaemia. Eye disorders: Glaucoma. Skin disorders: Drug-induced skin disorders. Eczema and psoriasis. Pressure sores and leg ulcers. Section 4: Appendices. Medical abbreviations. Glossary. Index |
| 520 ## - SUMMARY, ETC. |
| Summary, etc |
A practical guide for the treatment of common diseases, this updated edition includes the very latest information. It covers the treatment of disease by drug therapy and uses case studies to illustrate the application of the principles discussed |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Therapeutics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacy. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug Therapy. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacology, Clinical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Walker, Roger, |
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Whittlesea, Cate. |
| 9 (RLIN) |
1719 |
| Relator term |
author. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |